BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17139526)

  • 21. Periodic paralysis.
    Fontaine B
    Adv Genet; 2008; 63():3-23. PubMed ID: 19185183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periodic paralysis.
    Fialho D; Griggs RC; Matthews E
    Handb Clin Neurol; 2018; 148():505-520. PubMed ID: 29478596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Muscle channelopathies. Myotonias and periodic paralyses].
    Jurkat-Rott K; Lerche H; Lehmann-Horn F
    Nervenarzt; 2011 Apr; 82(4):511-20; quiz 521. PubMed ID: 21484581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness.
    Weber MA; Nielles-Vallespin S; Essig M; Jurkat-Rott K; Kauczor HU; Lehmann-Horn F
    Neurology; 2006 Oct; 67(7):1151-8. PubMed ID: 16931510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The primary periodic paralyses: diagnosis, pathogenesis and treatment.
    Venance SL; Cannon SC; Fialho D; Fontaine B; Hanna MG; Ptacek LJ; Tristani-Firouzi M; Tawil R; Griggs RC;
    Brain; 2006 Jan; 129(Pt 1):8-17. PubMed ID: 16195244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis.
    Vicart S; Sternberg D; Fournier E; Ochsner F; Laforet P; Kuntzer T; Eymard B; Hainque B; Fontaine B
    Neurology; 2004 Dec; 63(11):2120-7. PubMed ID: 15596759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation.
    Jurkat-Rott K; Lehmann-Horn F
    Neurology; 2004 Mar; 62(6):1012-5. PubMed ID: 15037716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome.
    Bendahhou S; Donaldson MR; Plaster NM; Tristani-Firouzi M; Fu YH; Ptácek LJ
    J Biol Chem; 2003 Dec; 278(51):51779-85. PubMed ID: 14522976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis.
    Sternberg D; Tabti N; Fournier E; Hainque B; Fontaine B
    Neurology; 2003 Sep; 61(6):857-9. PubMed ID: 14504341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).
    Tristani-Firouzi M; Jensen JL; Donaldson MR; Sansone V; Meola G; Hahn A; Bendahhou S; Kwiecinski H; Fidzianska A; Plaster N; Fu YH; Ptacek LJ; Tawil R
    J Clin Invest; 2002 Aug; 110(3):381-8. PubMed ID: 12163457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes.
    Andelfinger G; Tapper AR; Welch RC; Vanoye CG; George AL; Benson DW
    Am J Hum Genet; 2002 Sep; 71(3):663-8. PubMed ID: 12148092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced inactivation and pH sensitivity of Na(+) channel mutations causing hypokalaemic periodic paralysis type II.
    Kuzmenkin A; Muncan V; Jurkat-Rott K; Hang C; Lerche H; Lehmann-Horn F; Mitrovic N
    Brain; 2002 Apr; 125(Pt 4):835-43. PubMed ID: 11912116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.
    Plaster NM; Tawil R; Tristani-Firouzi M; Canún S; Bendahhou S; Tsunoda A; Donaldson MR; Iannaccone ST; Brunt E; Barohn R; Clark J; Deymeer F; George AL; Fish FA; Hahn A; Nitu A; Ozdemir C; Serdaroglu P; Subramony SH; Wolfe G; Fu YH; Ptácek LJ
    Cell; 2001 May; 105(4):511-9. PubMed ID: 11371347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis.
    Abbott GW; Butler MH; Bendahhou S; Dalakas MC; Ptacek LJ; Goldstein SA
    Cell; 2001 Jan; 104(2):217-31. PubMed ID: 11207363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.
    Struyk AF; Scoggan KA; Bulman DE; Cannon SC
    J Neurosci; 2000 Dec; 20(23):8610-7. PubMed ID: 11102465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.
    Jurkat-Rott K; Mitrovic N; Hang C; Kouzmekine A; Iaizzo P; Herzog J; Lerche H; Nicole S; Vale-Santos J; Chauveau D; Fontaine B; Lehmann-Horn F
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9549-54. PubMed ID: 10944223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current.
    Ruff RL
    Neurology; 1999 Oct; 53(7):1556-63. PubMed ID: 10534267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes.
    Morrill JA; Cannon SC
    J Physiol; 1999 Oct; 520 Pt 2(Pt 2):321-36. PubMed ID: 10523403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voltage-gated ion channels and hereditary disease.
    Lehmann-Horn F; Jurkat-Rott K
    Physiol Rev; 1999 Oct; 79(4):1317-72. PubMed ID: 10508236
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.